Intervet India Profile
Key Indicators
- Authorised Capital ₹ 17.50 Cr
as on 24-10-2024
- Paid Up Capital ₹ 17.00 Cr
as on 24-10-2024
- Company Age 28 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.76 M
as on 24-10-2024
- Revenue 15.79%
(FY 2023)
- Profit 17.57%
(FY 2023)
- Ebitda 16.52%
(FY 2023)
- Net Worth 14.52%
(FY 2023)
- Total Assets 19.56%
(FY 2023)
About Intervet India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 17.50 Cr and a paid-up capital of Rs 17.00 Cr.
The company currently has active open charges totaling ₹0.76 M.
The Key Managerial Personnel (KMP) at Intervet India Private Limited India is Roopali Kamate as COMPANY SECRETARY. Yash Goyal, Rupesh Shah, and Barry Jr serve as directors at the Company.
- CIN/LLPIN
U52311MH1996PTC099536
- Company No.
099536
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 May 1996
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Intervet India?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yash Goyal  | Managing Director | 21-Jun-2012 | Current |
| Roopali Kamate | Company Secretary | 01-Aug-2016 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rupesh Shah | Whole-Time Director | 27-Nov-2018 | Current |
Barry Jr  | Director | 16-Jul-2019 | Current |
Financial Performance and Corporate Structure Insights of Intervet India.
Intervet India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.79% increase. The company also saw a substantial improvement in profitability, with a 17.57% increase in profit. The company's net worth Soared by an impressive increase of 14.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Intervet India?
In 2023, Intervet India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 12 Jun 2017 | ₹0.76 M | Open |
How Many Employees Work at Intervet India?
Intervet India has a workforce of 274 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Intervet India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Intervet India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
